ATE335505T1 - Saponin inaktivierte mykoplasma impfstoffe - Google Patents

Saponin inaktivierte mykoplasma impfstoffe

Info

Publication number: ATE335505T1
Authority: AT; Austria
Prior art keywords: saponin; vaccines; mycoplasma; inactivated mycoplasma; inactivated
Prior art date: 2001-05-03

Application number

AT02720307T

Other languages

English (en)

Inventor

Robin Ashley John Vet Nicholas

Original Assignee

Novartis Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-05-03

Filing date

2002-05-03

Publication date

2006-09-15

2002-05-03 Application filed by Novartis Ag filed Critical Novartis Ag

2006-09-15 Application granted granted Critical

2006-09-15 Publication of ATE335505T1 publication Critical patent/ATE335505T1/de

Links

241000204031 Mycoplasma Species 0.000 title abstract 2
239000001397 quillaja saponaria molina bark Substances 0.000 title abstract 2
229930182490 saponin Natural products 0.000 title abstract 2
150000007949 saponins Chemical class 0.000 title abstract 2
229960005486 vaccine Drugs 0.000 title abstract 2
241000283690 Bos taurus Species 0.000 abstract 1
241001138504 Mycoplasma bovis Species 0.000 abstract 1
241000178641 Mycoplasma mycoides subsp. mycoides SC Species 0.000 abstract 1
206010035664 Pneumonia Diseases 0.000 abstract 1
239000003795 chemical substances by application Substances 0.000 abstract 1
231100000676 disease causative agent Toxicity 0.000 abstract 1
239000012528 membrane Substances 0.000 abstract 1
238000000034 method Methods 0.000 abstract 1
239000000203 mixture Substances 0.000 abstract 1
238000011321 prophylaxis Methods 0.000 abstract 1
238000011282 treatment Methods 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/0241—Mollicutes, e.g. Mycoplasma, Erysipelothrix
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55577—Saponins; Quil A; QS21; ISCOMS

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Immunology (AREA)
Microbiology (AREA)
Mycology (AREA)
Epidemiology (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)

AT02720307T 2001-05-03 2002-05-03 Saponin inaktivierte mykoplasma impfstoffe ATE335505T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GBGB0110851.3A GB0110851D0 (en)	2001-05-03	2001-05-03	Vaccine

Publications (1)

Publication Number	Publication Date
ATE335505T1 true ATE335505T1 (de)	2006-09-15

Family

ID=9913953

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT02720307T ATE335505T1 (de)	2001-05-03	2002-05-03	Saponin inaktivierte mykoplasma impfstoffe

Country Status (12)

Country	Link
US (1)	US20040170652A1 (de)
EP (1)	EP1387693B1 (de)
AT (1)	ATE335505T1 (de)
CA (1)	CA2445997A1 (de)
CY (1)	CY1107538T1 (de)
DE (1)	DE60213785T2 (de)
DK (1)	DK1387693T3 (de)
ES (1)	ES2269672T3 (de)
GB (1)	GB0110851D0 (de)
MX (1)	MXPA03010053A (de)
PT (1)	PT1387693E (de)
WO (1)	WO2002089838A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SE0301436D0 (sv) *	2003-05-16	2003-05-16	Joakim Westberg	New proteins
US20070009545A1 (en)	2005-07-07	2007-01-11	Joachim Frey	Mycoplasma subunit vaccine
CN101721694B (zh) *	2009-11-07	2013-01-30	中国农业科学院兰州兽医研究所	山羊支原体肺炎二联灭活疫苗及其制备方法
CA2995101A1 (en)	2015-08-14	2017-02-23	Zoetis Services Llc	Mycoplasma bovis compositions
CN110551653A (zh) *	2019-09-04	2019-12-10	中国农业科学院兰州兽医研究所	一种无血清制备牛支原体抗原的方法
CN110551634A (zh) *	2019-09-04	2019-12-10	中国农业科学院兰州兽医研究所	一种山羊支原体山羊肺炎亚种分离培养方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS5540568B2 (de) *	1972-10-05	1980-10-18
GB9108682D0 (en) *	1991-04-23	1991-06-12	Wellcome Found	Production of vaccines
CA2183684C (en) *	1994-02-18	2008-07-15	Richard D. Hansen	Inoculation of animals with dried, pelleted biological materials
BR0015398A (pt) *	1999-11-08	2002-06-25	Biomune	Vacinas para mycoplasma bovis e processos de uso
US6548069B2 (en) *	2001-02-03	2003-04-15	Hmv Associates, Inc.	Multivalent Mycoplasma bacterin

2001
- 2001-05-03 GB GBGB0110851.3A patent/GB0110851D0/en not_active Ceased
2002
- 2002-05-03 CA CA002445997A patent/CA2445997A1/en not_active Abandoned
- 2002-05-03 EP EP02720307A patent/EP1387693B1/de not_active Expired - Lifetime
- 2002-05-03 MX MXPA03010053A patent/MXPA03010053A/es active IP Right Grant
- 2002-05-03 PT PT02720307T patent/PT1387693E/pt unknown
- 2002-05-03 DK DK02720307T patent/DK1387693T3/da active
- 2002-05-03 AT AT02720307T patent/ATE335505T1/de not_active IP Right Cessation
- 2002-05-03 US US10/476,508 patent/US20040170652A1/en not_active Abandoned
- 2002-05-03 ES ES02720307T patent/ES2269672T3/es not_active Expired - Lifetime
- 2002-05-03 WO PCT/GB2002/002062 patent/WO2002089838A1/en not_active Ceased
- 2002-05-03 DE DE60213785T patent/DE60213785T2/de not_active Expired - Lifetime
2006
- 2006-10-24 CY CY20061101522T patent/CY1107538T1/el unknown

Also Published As

Publication number	Publication date
CA2445997A1 (en)	2002-11-14
DK1387693T3 (da)	2006-11-13
GB0110851D0 (en)	2001-06-27
CY1107538T1 (el)	2013-03-13
ES2269672T3 (es)	2007-04-01
EP1387693B1 (de)	2006-08-09
DE60213785T2 (de)	2007-08-23
US20040170652A1 (en)	2004-09-02
WO2002089838A1 (en)	2002-11-14
PT1387693E (pt)	2006-12-29
EP1387693A1 (de)	2004-02-11
DE60213785D1 (de)	2006-09-21
MXPA03010053A (es)	2004-03-09

Similar Documents

Publication	Publication Date	Title
PH12021550318A1 (en)	2021-10-04	Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
MY192183A (en)	2022-08-05	Immunogenic compositions comprising conjugated capsular saccharide antigens, kits comprising the same and uses thereof
DOP2024000040A (es)	2024-04-15	Vacunas para vhb y métodos de tratamiento de vhb
PH12017501898A1 (en)	2018-03-05	Group b streptococcus polysaccharide-protein conjugates, methods for producing conjugates, immunogenic compositions comprising conjugates, and uses thereof
BR112018007812A2 (pt)	2019-01-29	polissacarídeo capsular, processo para preparar um polissacarídeo capsular e para fabricar uma vacina, composição imunogênica, vacina, métodos para tratamento ou prevenção de uma infecção, para imunizar um hospedeiro humano e para induzir uma resposta imune, e, uso de uma composição imunogênica.
UY26783A1 (es)	2002-01-31	Antígenos de estreptococo.
IN2014CN04187A (de)	2015-07-17
DK1326633T3 (da)	2011-07-04	Sammensætning omfattende immunogene mikropartikler
MX2018015361A (es)	2019-03-11	Formulacion de vacuna contra el vih.
DK2054431T3 (da)	2012-01-02	Konformere af bakterielle adhæsiner
PH12021550484A1 (en)	2021-10-11	Immunological adjuvant and vaccine composition including sting agonist
UA98506C2 (en)	2012-05-25	Attenuated mycoplasma gallisepticum strains
MX2020008454A (es)	2021-03-25	Composicion inmunogenica que comprende antigenos estafilococicos.
AU2017241669A1 (en)	2018-11-22	Live, attenuated alphavirus constructs and methods and uses thereof
ATE335505T1 (de)	2006-09-15	Saponin inaktivierte mykoplasma impfstoffe
WO2021247715A3 (en)	2022-01-13	Immunogenic francisella antigens and their use in immunization of fish against francisellosis
MX2024005262A (es)	2024-09-19	Prototipo de vacuna de glucoconjugado sintético contra streptococcus suis.
MX2018012270A (es)	2019-08-14	Novedosas formulaciones de vacuna neumococica.
ATE404218T1 (de)	2008-08-15	Rekombinante bcg-impfstoffe gegen intrazelluläre pathogene und anwendungsverfahren
BRPI0608310A2 (pt)	2009-12-08	uso de um poxvìrus modificado para a indução rápida de imunidade contra um poxvìrus ou outros agentes infecciosos
EP4635510A3 (de)	2026-03-25	Kombinationsimpfstoff
MX2022001937A (es)	2022-03-11	Composicion inmunogenica.
CL2022000086A1 (es)	2022-09-30	Vacunas contra ehrlichia y composiciones inmunogénicas
MX2022015860A (es)	2023-01-24	Inmunizacion bacteriana que utiliza una vacuna con nanoparticulas.
MY190074A (en)	2022-03-24	A monovalent vaccine formulation and a method for preparation thereof

Legal Events

Date

Code

Title

Description

2007-05-15

UEP

Publication of translation of european patent specification

Ref document number: 1387693

Country of ref document: EP

2012-02-15

REN

Ceased due to non-payment of the annual fee